Relmada Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Coral Gables, FL
RLMD chart
What traders are saying about $RLMD
Latest postsRelmada Therapeutics, Inc. news
- Relmada Therapeutics Inc expected to post a loss of 14 cents a share - Earnings Preview
TradingView ·
- Relmada Therapeutics, Inc. (4E2.SG) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Relmada Therapeutics, Inc. (4E2.SG) Seasonal returns chart
Yahoo Finance Singapore ·
- Relmada Therapeutics, Inc. (4E2.SG) Latest Press Releases & Corporate News - Yahoo Finance
Yahoo! Finance Canada ·
- Relmada Therapeutics, Inc. (4E2.SG) stock price, news, quote and history
Yahoo Finance Singapore ·
- Relmada Therapeutics to present at Jefferies Gl...
Pluang ·
- Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London
Yahoo Finance ·
- Relmada Therapeutics, Inc. (4E2.SG) Interactive Stock Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
Yahoo Finance ·
- 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery
Yahoo Finance ·
- Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
Yahoo Finance ·
- After Plunging 18.5% in 4 Weeks, Here's Why the Trend Might Reverse for Relmada Therapeutics (RLMD)
Yahoo Finance ·
Relmada Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $0 | $0 | $0 | -$157.0M |
| Diluted EPS | $-1.45 | $-2.65 | $-3.28 | $-5.30 |
| Total assets (year end) | $94.0M | $45.8M | $97.6M | $152.9M |
| Cash and equivalents (year end) | $3.5M | $3.9M | $4.1M | $5.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 10-QQUARTERLY REPORT
- DEF 14APROXY STATEMENT
- 8-KCURRENT REPORT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
About Relmada Therapeutics, Inc.
- Ticker
- RLMD (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Coral Gables, FL
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 1553643
- Former names
- CAMP NINE, INC.
Frequently asked questions
What exchange is Relmada Therapeutics, Inc. listed on?
Relmada Therapeutics, Inc. trades on the Nasdaq under the ticker symbol RLMD.
What industry is Relmada Therapeutics, Inc. in?
Relmada Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Relmada Therapeutics, Inc. headquartered?
Relmada Therapeutics, Inc.'s business address on file with the SEC is in Coral Gables, FL.
When does Relmada Therapeutics, Inc.'s fiscal year end?
Relmada Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Relmada Therapeutics, Inc. report?
Relmada Therapeutics, Inc. reported $5,129 in revenue for calendar year 2013, according to its SEC filings.